DWS runs €2.3bn in a single active German equity strategy, split across four share classes charging either 0.70% or 0.40% a year. The portfolio underneath is the same. The question is what either fee is actually buying — and whether a concentrated single-country bet in one of Europe’s most politically exposed markets earns its keep against a cheaper alternative.
What you’re actually buying
The DWS Aktien Strategie Deutschland range comes in two pairs. The accumulating classes — DWS Aktien Strategie Deutschland FC and IC — reinvest any income. The income-paying equivalents are FD and ID. Within each pair, the F-class (FC and FD) carries a 0.70% annual fee (OCF); the I-class (IC and ID) costs 0.40%.
That 0.30 percentage-point gap is the share-class discipline point worth pausing on. The IC and ID classes are institutional — they are not available on a standard retail platform. If you are a private investor, you are looking at FC or FD at 0.70%, full stop. The cheaper classes exist, but they are not your number.
With that settled, the real question is what 0.70% buys in practice. This is an active, single-country strategy focused entirely on German equities. No diversification by geography, no tilt toward European peers when Germany is out of favour. The manager is paid to run a concentrated book of German stocks — and to be right about them consistently enough to justify the fee over a cheaper passive alternative.
Why the single-country bet is the harder question
German equities carry a specific risk profile that broad European or global allocations dilute naturally. The German economy is industrially heavy — autos, chemicals, engineering — and more exposed than most developed markets to energy-price shocks, Chinese demand cycles, and the structural repricing of export-led manufacturing in a higher-tariff world. None of that is hidden; it is the reason some investors want Germany specifically. But it means the concentration risk here is not just “one country”. It is one country with a particular set of macro sensitivities that can all move in the same direction at once.
An active manager running this strategy has to do two things well. First, pick the right German stocks — avoiding the most vulnerable cyclicals in a downturn, finding the compounders that the DAX-weighted tracker overweights or underweights. Second, add enough through that selection to cover the 0.70% fee against the passive alternative. That is not an unreasonable bar, but it is a bar that gets harder as the fee climbs.
A single-country active bet needs two things to work: the right country call, and a manager who outpicks the index. Both have to come good at once.
The data block here does not include performance figures, so a direct comparison against an index is not possible from the numbers provided. What the €2.3bn pooled AUM across all four share classes does tell you is that this is not a niche product. It has attracted serious institutional and retail capital. Whether that capital has been well-served over a five-year period is the question you should put to your platform or adviser before committing.
What to watch next
Three signals are worth tracking. First, German political and fiscal developments — the strategy’s fortunes are directly tied to Germany’s ability to restore industrial competitiveness and manage its energy transition, and any material policy shift in Berlin lands in this portfolio. Second, the spread between FC/FD retail performance and a passive Germany tracker: if the active premium shrinks toward zero over a rolling three-year window, the fee case weakens sharply. And third, whether DWS introduces a lower-cost retail share class — pressure on fees across the European active fund industry is real, and a 0.70% active Germany product is not cheap by the standards of where this market is heading. The share-class structure is the thing to watch most: what is institutional today sometimes becomes retail tomorrow, and the 0.30 percentage-point gap is wide enough to matter compounded over a decade.
Past performance is not a guide to future returns. Capital is at risk.
Funds Benchmark provides research and tooling for institutional and private investors. Nothing in this note is investment advice or a recommendation to buy or sell any specific fund. Past performance is not a reliable indicator of future results.